Faeth Therapeutics, Inc.

FTH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001829802

SEC filings (opens in a new tab)

No open-market purchases or sales by Faeth Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Faeth Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of FTH: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Q3 2021	Change
Holders	34	42	+8
Shares	2.32M	3.53M	+1.21M (+51.9%)
Value	$22.7M	$37.1M	+$14.4M (+63.6%)

New holders (14)

Institutions that held Faeth Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to FTH in Q3 2021
Institution	Shares	Value	% of portfolio
Millennium Management LLC	258,659	$2.72M	0.00%
Truist Financial Corp	70,374	$740.0K	0.00%
Mission Creek Capital Partners, Inc.	32,784	$345.0K	0.06%
Tao Capital Management LP	32,784	$345.0K	0.09%
Rhumbline Advisers	16,579	$174.0K	0.00%
BFT Financial Group, LLC	14,845	$156.0K	0.03%
Manufacturers Life Insurance Company, The	13,478	$142.0K	0.00%
SG Americas Securities, LLC	12,614	$133.0K	0.00%
Jane Street Group, LLC	10,773	$113.0K	0.00%
Investment Research & Advisory Group, Inc.	1,400	$5.00K	0.00%
US Bancorp	91	$1.00K	0.00%
Signaturefd, LLC	142	$1.00K	0.00%
Parallel Advisors, LLC	54	$1.00K	0.00%
Lindbrook Capital, LLC	27	$0	0.00%

Sold out (6)

Institutions that held Faeth Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of FTH in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Formula Growth Ltd	100,000	$976.0K
Zimmer Partners, LP	46,000	$449.0K
Alyeska Investment Group, L.P.	40,000	$390.0K
Tudor Investment Corp Et Al	28,111	$274.0K
Two Sigma Advisers, LP	23,200	$226.0K
Two Sigma Investments, LP	18,551	$181.0K